Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Medullary × pasireotide × Clear all

Sponsor

Conditions

Pituitary Neoplasms 4 Prostatic Neoplasms 3 Pituitary ACTH Hypersecretion 2 Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Neoplasms 2 Carcinoid Tumor 2 Acromegaly 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Serotonin Syndrome 1 Prolactinoma 1 Primary Inoperable Thymoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neuroectodermal Tumors, Primitive 1 Neoplasm Metastasis 1 Nelson Syndrome 1 Myelodysplastic Syndromes 1 Meningioma 1 Melanoma 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematologic Neoplasms 1 Growth Disorders 1 Gigantism 1 Gastro-enteropancreatic neuroendocrine tumor 1 Dumping Syndrome 1 Carcinoma, Neuroendocrine 1 Carcinoma, Hepatocellular 1

Interventions

vandetanib 9 cabozantinib 4 selpercatinib 3 Sunitinib 2 Sorafenib 2 yeast-CEA vaccine 1 tanespimycin 1 pralsetinib 1 pembrolizumab 1 pazopanib 1 lenvatinib 1 Vorinostat 1 Temozolomide 1 Pharmacogenomic Testing 1 Magnetic Resonance Spectroscopy 1 Lithium Carbonate 1 Irinotecan 1 Gefitinib 1 Ferrosoferric Oxide 1 Capecitabine 1 Bortezomib 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡